2016年11月2日
Wellesley, Mass., Nov 2, 2016 – The rising global demand for organ transplantation is driving technological innovation.乐动体育-西甲2019赞助商reveals in its new report that next-generation sequencing (NGS) is the latest technology trend dominating the competitive landscape of the global transplant diagnostics market.
The transplant diagnostics market offers a platform for organ and tissue transplant procedures by providing reduced error and high accuracy in the methods for carrying out human leukocyte antigen (HLA) typing. To ensure a compatible match between the donor and recipient, the HLA diagnostic test is performed before the organ transplant. The global transplant diagnostics market comprises four segments: components, end users, applications, and regions.
The global transplant diagnostics market should reach $564.2 million and $899.3 million in 2016 and 2021, respectively, growing at a five-year CAGR of 9.8%. Among the major regions, Asia-Pacific should grow the fastest with an anticipated five-year (2016-2021) CAGR of 11.1%. North America, the largest region, should demonstrate a five-year CAGR of 9.6% during the same period.
From a regional perspective, the market should experience rapid growth in developed economies such as the United States and Europe. Continual initiatives by government bodies, medical associations, and key market players are spurring market growth in these two regions. However, both regions face challenges due to a lack of awareness and information about the importance of organ donations and transplant procedures, which are pivotal for growth.
Certain factors such as challenges of HLA sequencing and gaps in supply and demand may constrain market growth. For example, the growing need for organ transplants butts up against the shortage of organs worldwide, which limits the number of transplant procedures performed, which adversely affects the transplant diagnostics procedures.
Market players continue to focus on developing innovative products that can revolutionize the transplant diagnostics market, like NGS. This technology reduces the amount of time and number of errors in transplant diagnostics while also delivering high-quality results for donor and recipient matches.
BCC研究分析师Yojana Jeevane说：“随着NGS的引入，市场发生了范式转变。NGS允许一次并行处理数百万个序列读取。”乐动体育-西甲2019赞助商“这种便利性使移植诊断市场的主要参与者能够专注于这项技术，从而获得HLA打字的准确结果。这种可以提供高质量结果的创新对于移植诊断市场将很重要。”
移植诊断：技术和全球市场(HLC193A) analyzes the technology, applications, and end-users of transplant diagnostic tests by regional segments and sub-segments. The report also evaluates novel and future approaches in terms of biomarkers, bio-printing, and organoidsexamines. Global market drivers and trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021 also are provided.
Editors and reporters who wish to speak with the analyst should contact Steven Cumming atsteven.cumming@bccresearch.com.
移植诊断：技术和全球市场( HLC193A )
Publish Date:Oct 2016
Data and analysis extracted from this press release must be accompanied by a statement identifyingBCC Research LLCas the source and publisher. For media inquiries, emailpress@bccresearch.comor visitwww.aflcchurches.org/mediato request access to our library of market research.